Current management of prostatic carcinoma
- PMID: 3909178
Current management of prostatic carcinoma
Abstract
Carcinoma of the prostate is the second most common cancer in men. Its exact cause is unknown, but genetic, hormonal, environmental, and infectious factors have all been implicated. There are numerous treatment options available for patients with each stage of prostatic cancer, and it is not desirable to make categoric treatment recommendations. Treatment plans should be tailored to the individual needs of the patient. Although no therapy is uniformly effective, the judicious selection of the available treatment options can minimize the mortality and morbidity associated with prostatic cancer.
Similar articles
-
Management of newly diagnosed metastatic carcinoma of the prostate.Urol Clin North Am. 1984 May;11(2):283-95. Urol Clin North Am. 1984. PMID: 6428022 Review.
-
Treatment of stage IV carcinoma of the prostate.Urol Clin North Am. 1975 Feb;2(1):141-61. Urol Clin North Am. 1975. PMID: 1093057 Review.
-
Prostatic oncology.Clin Geriatr Med. 1990 Feb;6(1):131-61. Clin Geriatr Med. 1990. PMID: 2405975 Review.
-
The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.Urol Clin North Am. 1994 Nov;21(4):707-15. Urol Clin North Am. 1994. PMID: 7974899 Review.
-
[Cancer of the prostate stage T1. Incidental carcinoma. Review of the literature and an appraisal of the classification].Ann Urol (Paris). 1994;28(4):229-34. Ann Urol (Paris). 1994. PMID: 7979213 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical